Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02514525 · ClinicalTrials.gov registry record · NA
Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System
A NA study of Barrett Esophagus, sponsored by Pentax Medical.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 11
- Study locations
NCT02514525 is a NA study of Barrett Esophagus that is active but no longer recruiting, run by Pentax Medical. The registered enrollment target is 150 participants, below the 3,561-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (96% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT02514525, a NA study of Barrett Esophagus, is active but no longer recruiting, sponsored by Pentax Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 11
- Study locations
Study Summary
To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") Barrett's Esophagus (BE)
Conditions Studied
Interventions
- DEVICE CryoBalloon Ablation System
Study Locations (11)
New York
- Northwell Health - Manhasset
- New York Presbyterian Hospital-Columbia University Medical Center - New York
Pennsylvania
- Geisinger Medical Center - Danville
- Thomas Jefferson University - Philadelphia
California
- UC Irvine - Orange
Florida
- Sarasota Memorial Hospital - Sarasota
Illinois
- University of Chicago - Chicago
Maryland
- John Hopkins - Baltimore
Minnesota
- Mayo Clinic - Rochester
North Carolina
- University of North Carolina School of Medicine - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-03 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02514525
The ClinicalTrials.gov registry entry for NCT02514525 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,561-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (96% lower). The listed sponsor is Pentax Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which CryoBalloon Ablation System is the first listed.
NCT02514525 reports 11 study locations spanning 9 distinct geographic areas - top geographies include New York, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT02514525 about?
NCT02514525 is a clinical study titled "Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System". To evaluate the efficacy and safety of the CryoBalloon Focal Ablation System for the treatment of previously-untreated ("treatment naïve") Barrett's Esophagus (BE)
What is the current status of trial NCT02514525?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2016-03. Estimated completion is 2025-12.
What conditions does trial NCT02514525 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT02514525?
The interventions under investigation include: CryoBalloon Ablation System (DEVICE).
Who is sponsoring clinical trial NCT02514525?
This trial is sponsored by Pentax Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02514525 being conducted?
This trial has 11 study locations across California, Florida, Illinois, Maryland, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.